Diabetes Drug Market Size to Surpass USD 145 Billion by 2032 at a CAGR of 6.9%, Fueled by Rising Global Diabetes Prevalence – SNS Insider
Global Diabetes Drug Market growth is driven by the rising incidence of diabetes and increasing adoption of innovative treatment solutions.Austin, United States, Feb. 10, 2025 (GLOBE NEWSWIRE) -- ...
The Indian Express27d
Is inhaled insulin better for blood sugar control? Here’s what studies show
Story continues below this ad An inhaled form of insulin (Exubera) was available for a short time (2006-2007) but failed to gain acceptance by patients and clinicians. This was largely due to the ...
Khaleej Times18y
MoH okays insulin inhaler for diabetics
“Exubera, the first inhaled form of insulin, has won the approval of the Higher Drugs Registration Committee at MoH,” disclosed Dr Issa bin Jakka Al Mansouri, Director of the Drug Control ...